Inositol hexakisphosphate kinase-1 interacts with perilipin1 to modulate lipolysis

International Journal of Biochemistry and Cell Biology

Volumn 78, Issue , 2016, Pages 149-155

  Ghoshal, Sarbani ^a   Tyagi, Richa ^b   Zhu, Qingzhang ^a   Chakraborty, Anutosh ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; IP6K; Lipolysis; Obesity; Perilipin

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; INOSITOL HEXAKISPHOSPHATE KINASE 1; INOSITOL PHOSPHATE; INSULIN; PERILIPIN 1; PROTEIN KINASE C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; IHPK1 PROTEIN, MOUSE; PHOSPHOTRANSFERASE; PROTEIN BINDING;

ANIMAL EXPERIMENT; ARTICLE; ENERGY EXPENDITURE; ENZYME PHOSPHORYLATION; HEK293 CELL LINE; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIPOLYSIS; MALE; MASS SPECTROMETRY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN PROTEIN INTERACTION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; DEFICIENCY; GENE INACTIVATION; GENETICS; METABOLISM; PHOSPHORYLATION;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE KNOCKOUT TECHNIQUES; LIPOLYSIS; MALE; MICE; PERILIPIN-1; PHOSPHORYLATION; PHOSPHOTRANSFERASES (PHOSPHATE GROUP ACCEPTOR); PROTEIN BINDING; PROTEIN KINASE C;

EID: 84978416104     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2016.06.018     Document Type: Article

References (42)

1. Ahmadian, M., Duncan, R.E., Sul, H.S., The skinny on fat: lipolysis and fatty acid utilization in adipocytes. Trends Endocrinol. Metab. 20 (2009), 424–428.
2. Barker, C.J., Illies, C., Gaboardi, G.C., Berggren, P.O., Inositol pyrophosphates: structure, enzymology and function. Cell. Mol. Life Sci. 66 (2009), 3851–3871.
3. Bhandari, R., Juluri, K.R., Resnick, A.C., Snyder, S.H., Gene deletion of inositol hexakisphosphate kinase 1 reveals inositol pyrophosphate regulation of insulin secretion, growth, and spermiogenesis. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 2349–2353.
4. Boden, G., Obesity and free fatty acids. Endocrinol. Metab. Clin. North Am. 37 (2008), 635–646 (viii-ix).
5. Boucher, J., Kleinridders, A., Kahn, C.R., Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect. Biol., 6, 2014, a009191.
6. Brasaemle, D., Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J. Lipid Res. 48 (2007), 2547–2559.
7. Chakraborty, A., Koldobskiy, M.A., Bello, N.T., Maxwell, M., Potter, J.J., Juluri, K.R., Maag, D., Kim, S., Huang, A.S., Dailey, M.J., Saleh, M., Snowman, A.M., Moran, T.H., Mezey, E., Snyder, S.H., Inositol pyrophosphates inhibit Akt signaling, regulate insulin sensitivity and weight gain. Cell 143 (2010), 897–910.
8. Chakraborty, A., Kim, S., Snyder, S.H., Inositol pyrophosphates as mammalian cell signals. Sci. Signal., 4, 2011, re1.
9. Fu, C., Xu, J., Li, R.J., Crawford, J.A., Khan, A.B., Ma, T.M., Cha, J.Y., Snowman, A.M., Pletnikov, M.V., Snyder, S.H., Inositol hexakisphosphate kinase-3 regulates the morphology and synapse formation of cerebellar purkinje cells via Spectrin/Adducin. J. Neurosci. 35 (2015), 11056–11067.
10. Gauthier, M.S., Miyoshi, H., Souza, S.C., Cacicedo, J.M., Saha, A.K., Greenberg, A.S., Ruderman, N.B., AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance. J. Biol. Chem. 283 (2008), 16514–16524.
11. Gokhale, N.A., Zaremba, A., Janoshazi, A.K., Weaver, J.D., Shears, S.B., PPIP5K1 modulates ligand competition between diphosphoinositol polyphosphates and PtdIns(3,4,5)P3 for polyphosphoinositide-binding domains. Biochem. J 453 (2013), 413–426.
12. Grujic, D., Susulic, V.S., Harper, M.E., Himms-Hagen, J., Cunningham, B.A., Corkey, B.E., Lowell, B.B., Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J. Biol. Chem. 272 (1997), 17686–17693.
13. Illies, C., Gromada, J., Fiume, R., Leibiger, B., Yu, J., Juhl, K., Yang, S.N., Barma, D.K., Falck, J.R., Saiardi, A., Barker, C.J., Berggren, P.O., Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells. Science 318 (2007), 1299–1302.
14. Koldobskiy, M.A., Chakraborty, A., Werner, J.K. Jr, Snowman, A.M., Juluri, K.R., Vandiver, M.S., Kim, S., Heletz, S., Snyder, S.H., p53-mediated apoptosis requires inositol hexakisphosphate kinase-2. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 20947–20951.
15. Kozusko, K., Patel, S., Savage, D.B., Human congenital perilipin deficiency and insulin resistance. Endocr. Dev. 24 (2013), 150–155.
16. Langin, D., Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol. Res. 53 (2006), 482–491.
17. Lucas, S., Tavernier, G., Tiraby, C., Mairal, A., Langin, D., Expression of human hormone-sensitive lipase in white adipose tissue of transgenic mice increases lipase activity but does not enhance in vitro lipolysis. J. Lipid Res. 44 (2003), 154–163.
18. Mackenzie, W.A. Richard, Elliott, T. Bradley, Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes. Diabetes Metab. Syndr. Obes. 13 (2014), 55–64.
19. Martinez-Botas, J., Anderson, J.B., Tessier, D., Lapillonne, A., Chang, B.H., Quast, M.J., Gorenstein, D., Chen, K.H., Chan, L., Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat. Genet. 26 (2000), 474–479.
20. McManaman, J.L., Bales, E.S., Orlicky, D.J., Jackman, M., MacLean, P.S., Cain, S., Crunk, A.E., Mansur, A., Graham, C.E., Bowman, T.A., Greenberg, A.S., Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease. J. Lipid Res. 54 (2013), 1346–1359.
21. Morrison, B.H., Haney, R., Lamarre, E., Drazba, J., Prestwich, G.D., Lindner, D.J., Gene deletion of inositol hexakisphosphate kinase 2 predisposes to aerodigestive tract carcinoma. Oncogene 28 (2009), 2383–2392.
22. Prasad, A., Jia, Y., Chakraborty, A., Li, Y., Jain, S.K., Zhong, J., Roy, S.G., Loison, F., Mondal, S., Sakai, J., Blanchard, C., Snyder, S.H., Luo, H.R., Inositol hexakisphosphate kinase 1 regulates neutrophil function in innate immunity by inhibiting phosphatidylinositol-(3,4,5)-trisphosphate signaling. Nat. Immunol. 12 (2011), 752–760.
23. Qiao, L., Kinney, B., Schaack, J., Shao, J., Adiponectin inhibits lipolysis in mouse adipocytes. Diabetes 60 (2011), 1519–1527.
24. Rao, F., Xu, J., Fu, C., Cha, J.Y., Gadalla, M.M., Xu, R., Barrow, J.C., Snyder, S.H., Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1. Proc. Natl. Acad. Sci. U. S. A., 2015.
25. Roth Flach, R.J., Matevossian, A., Akie, T.E., Negrin, K.A., Paul, M.T., Czech, M.P., β3-Adrenergic receptor stimulation induces E-selectin-mediated adipose tissue inflammation. J. Biol. Chem. 288 (2013), 2882–2892.
26. Saha, P.K., Kojima, H., Martinez-Botas, J., Sunehag, A.L., Chan, L., Metabolic adaptations in the absence of perilipin: increased beta-oxidation and decreased hepatic glucose production associated with peripheral insulin resistance but normal glucose tolerance in perilipin-null mice. J. Biol. Chem. 279 (2004), 35150–35158.
27. Saiardi, A., Erdjument-Bromage, H., Snowman, A.M., Tempst, P., Snyder, S.H., Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases. Curr. Biol. 9 (1999), 1323–1326.
28. Shears, S., Towards pharmacological intervention in inositol pyrophosphate signalling. Biochem. Soc. Trans. 44 (2016), 191–196.
29. Skinner, J.R., Lydia-Ann Harris, L.S., Trevor Shew, M., Nada Abumrad, A., Nathan Wolins, E., Perilipin 1 moves between the fat droplet and the endoplasmic reticulum. Adipocyte 2 (2013), 80–86.
30. Szijgyarto, Z., Garedew, A., Azevedo, C., Saiardi, A., Influence of inositol pyrophosphates on cellular energy dynamics. Science 334 (2011), 802–805.
31. Tansey, J.T., Sztalryd, C., Gruia-Gray, J., Roush, D.L., Zee, J.V., Gavrilova, O., Reitman, M.L., Deng, C.X., Li, C., Kimmel, A.R., Londos, C., Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 6494–6499.
32. Taschler, U., Radner, F.P., Heier, C., Schreiber, R., Schweiger, M., Schoiswohl, G., Preiss-Landl, K., Jaeger, D., Reiter, B., Koefeler, H.C., Wojciechowski, J., Theussl, C., Penninger, J.M., Lass, A., Haemmerle, G., Zechner, R., Zimmermann, R., Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. J. Biol. Chem. 286 (2011), 17467–17477.
33. Thota, S.G., Bhandari, R., The emerging roles of inositol pyrophosphates in eukaryotic cell physiology. J. Biosci. 40 (2015), 593–605 Review.
34. Thrush, A.B., Gagnon, A., Sorisky, A., PKC activation is required for TSH-mediated lipolysis via perilipin activation. Horm. Metab. Res. 44 (2012), 825–831.
35. Wilson, M.S., Livermore, T.M., Saiardi, A., Inositol pyrophosphates: between signalling and metabolism. Biochem. J. 452 (2013), 369–379.
36. Wong, H., Schotz, M.C., The lipase gene family. J. Lipid Res. 43 (2002), 993–999.
37. Wu, M., Dul, B.E., Trevisan, A.J., Fiedler, D., Synthesis and characterization of non-hydrolysable diphosphoinositol polyphosphate second messengers. Chem. Sci. 4 (2013), 405–410.
38. Xu, Y., Li, H., Bajrami, B., Kwak, H., Cao, S., Liu, P., Zhou, J., Zhou, Y., Zhu, H., Ye, K., Luo, H.R., Cigarette smoke (CS) and nicotine delay neutrophil spontaneous death via suppressing production of diphosphoinositol pentakisphosphate. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 7726–7731.
39. Young, S.G., Rudolf, Z., Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev. 27 (2013), 459–484.
40. Zebisch, K., Voigt, V., Wabitsch, M., Brandsch, M., Protocol for effective differentiation of 3T3-L1 cells to adipocytes. Anal. Biochem. 425 (2012), 88–90.
41. Zhang, Z., Liang, D., Gao, X., Zhao, C., Qin, X., Xu, Y., Su, T., Sun, D., Li, W., Wang, H., Liu, B., Cao, F., Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction. Basic Res. Cardiol., 109, 2014, 417.
42. Zhang, Z., Zhao, C., Liu, B., Liang, D., Qin, X., Li, X., Zhang, R., Li, C., Wang, H., Sun, D., Cao, F., Inositol pyrophosphates mediate the effects of aging on bone marrow mesenchymal stem cells by inhibiting Akt signaling. Stem Cell Res. Ther., 5, 2014, 33.